Shanghai MicroPort EV MedTech Co. Ltd. A - Asset Resilience Ratio
Shanghai MicroPort EV MedTech Co. Ltd. A (688351) has an Asset Resilience Ratio of 51.53% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 688351 liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how Shanghai MicroPort EV MedTech Co. Ltd. A's Asset Resilience Ratio has changed over time. See 688351 total equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Shanghai MicroPort EV MedTech Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 688351 market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.03 Billion | 51.53% |
| Total Liquid Assets | CN¥1.03 Billion | 51.53% |
Asset Resilience Insights
- Very High Liquidity: Shanghai MicroPort EV MedTech Co. Ltd. A maintains exceptional liquid asset reserves at 51.53% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Shanghai MicroPort EV MedTech Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Shanghai MicroPort EV MedTech Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 36.63% |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298 |
Medical Devices | 2.82% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 9.52% |
|
Guangdong Transtek Medical Electronics Co Ltd
SHE:300562 |
Medical Devices | 14.72% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.47% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 0.50% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.39% |
Annual Asset Resilience Ratio for Shanghai MicroPort EV MedTech Co. Ltd. A (2022–2025)
The table below shows the annual Asset Resilience Ratio data for Shanghai MicroPort EV MedTech Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 51.53% | CN¥1.03 Billion ≈ $150.28 Million |
CN¥1.99 Billion ≈ $291.65 Million |
-6.00pp |
| 2024-12-31 | 57.53% | CN¥1.09 Billion ≈ $159.41 Million |
CN¥1.89 Billion ≈ $277.11 Million |
-0.98pp |
| 2023-12-31 | 58.51% | CN¥1.07 Billion ≈ $156.10 Million |
CN¥1.82 Billion ≈ $266.80 Million |
+9.44pp |
| 2022-12-31 | 49.07% | CN¥879.61 Million ≈ $128.71 Million |
CN¥1.79 Billion ≈ $262.30 Million |
-- |
About Shanghai MicroPort EV MedTech Co. Ltd. A
Shanghai MicroPort EP MedTech Co., Ltd. engages in the research, development, production, and sale of medical devices in the field of electrophysiological interventional diagnosis and ablation therapy in China and internationally. The company offers cardiac ablation catheters, diagnostic catheters, and 3D navigation systems, as well as cryoablation solutions, such as ablation and diagnostic cathe… Read more